Seasoned investor and operator focusing on growth-stage technology and healthcare companies, with experience across venture capital and private equity. ARIN WESNITZER has led deal sourcing, portfolio strategy and board engagements, specializing in scale-ups, go-to-market execution and financial operations. Known for structuring growth financings and exits, leverages cross-border networks to support commercial expansion and M&A readiness.
Seasoned investor and operator focusing on growth-stage technology and healthcare companies, with experience across venture capital and private equity. ARIN WESNITZER has led deal sourcing, portfolio strategy and board engagements, specializing in scale-ups, go-to-market execution and financial operations. Known for structuring growth financings and exits, leverages cross-border networks to support commercial expansion and M&A readiness.
Focuses on growth-stage technology and healthcare businesses, deploying patient, stage-gated capital to drive scalable go-to-market and durable unit economics. Combines venture agility with private-equity rigor: prioritizes repeatable revenue models, strong margin improvement levers, and clear exit pathways. Investment decisions emphasize operational engagement, board-led governance, and KPI-driven restructurings to derisk expansion and M&A readiness. Prefers cross-border opportunities where commercial networks accelerate adoption; time horizon is growth-to-exit with disciplined downside protection and staged financing milestones.
Focuses on growth-stage technology and healthcare businesses, deploying patient, stage-gated capital to drive scalable go-to-market and durable unit economics. Combines venture agility with private-equity rigor: prioritizes repeatable revenue models, strong margin improvement levers, and clear exit pathways. Investment decisions emphasize operational engagement, board-led governance, and KPI-driven restructurings to derisk expansion and M&A readiness. Prefers cross-border opportunities where commercial networks accelerate adoption; time horizon is growth-to-exit with disciplined downside protection and staged financing milestones.
| Trades 1159 | Longs Won 821/1159 70% | Profit Factor 18.88 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $336,994.64 |
| Average Win $85,637.29 | Best Trade (Jul 17) $6.06M | Sharpe Ratio -10.52 |
| Average Loss -$11,017.27 | Worst Trade (Jul 10) -$376,123.75 | Z-Score 9.22 (100%) |
| Commissions $0 | Avg. Trade Length 1y 11m 1w 2d | Expectancy $57,449.04 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 14,493 | 13,043 | 11,594 | 10,145 | 8,696 | 7,246 | 5,797 | 4,348 | 2,899 | 1,449 |